Related Experiment Video
Updated: Feb 13, 2026

Isolation & Characterization of Hoechstlow CD45negative Mouse Lung Mesenchymal Stem Cells
Published on: October 26, 2011
Clinical applications of mesenchymal stem cells in chronic lung diseases
Katerina M Antoniou1,2, Konstantinos Karagiannis1,2, Eliza Tsitoura1
1Laboratory of Molecular and Cellular Pneumonology, Medical School, University of Crete, Heraklion 71110, Crete, Greece.
Abstract:
Mesenchymal stem (stromal) cells (MSCs) are multipotent stromal cells that have the ability to modulate immune response to tissue injury and promote repair in vivo. The therapeutic potential of ex vivo expanded MSCs are currently under investigation for a variety of chronic and acute lung diseases. This review summarizes the encouraging results regarding the safety of MSCs administration from recent and current clinical trials for idiopathic pulmonary fibrosis, acute respiratory distress syndrome, and chronic obstructive pulmonary disease. It also reviews the early preliminary data extracted by the same trials regarding the efficacy of MSCs in the aforementioned lung diseases.
More Related Videos
09:03Human Mesenchymal Stem Cell Processing for Clinical Applications Using a Closed Semi-Automated Workflow
Published on: March 17, 2023
09:45Generation of 3D Whole Lung Organoids from Induced Pluripotent Stem Cells for Modeling Lung Developmental Biology and Disease
Published on: April 12, 2021
Related Concept Videos
Clinical Applications of Epidermal Stem Cells
Chronic Kidney Disease II: Clinical Manifestations
Mesenchymal Stem Cells
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Kidney Disease I: Introduction
Chronic Obstructive Pulmonary Disease-I: Introduction